top of page
external-file_edited (1)_edited_edited_edited_edited.png

Hello.

Welcome to BioFocus. 
Explore the latest updates from the life science industry.

Popular Content.

​

Intuitive surpasses 10,000 robotic-assisted bronchoscopy procedures across Europe with Ion system

More than 10,000 robotic-assisted bronchoscopy procedures have now been performed across Europe using Intuitive’s Ion endoluminal system, marking a milestone in the adoption of technology designed to help clinicians access and biopsy difficult-to-reach lung nodules.

 Featured Articles. 

7-format11240.jpg
BIOTECH

£30m venture philanthropy fund launched to accelerate development of new myeloma treatments

7-format11240.jpg
EVENTS

BIX 2026 to explore the future of obesity treatments as full conference agenda is unveiled

7-format11240.jpg
BIOPROCESSING

Bio-Rad Expands Foresight Pro Chromatography Columns for Biomanufacturing

7-format11240.jpg
BIOTECH

Big Picture Bio launches with £2.2m to develop AI-designed cancer combination therapies

7-format11240.jpg
BIOTECH

Shift Bioscience says better benchmarking could make AI “virtual cells” more useful for finding ageing drug targets

7-format11240.jpg
PHARMA

EyePoint’s DURAVYU misses first Phase 3 endpoint in wet AMD, putting focus on second trial

7-format11240.jpg
HEALTH

The Eye's Hidden Drain, Discovered

7-format11240.jpg
BIOTECH

Houdini Bio: tackling the gene-silencing barrier in genetic medicines

7-format11240.jpg
PHARMA

AI, Forecasting, Insights and Analytics for Smarter Decisions in Pharma

 Latest News. 

12th November, 2026

01.

Mogrify reports preclinical evidence of retinal regeneration using in vivo cell reprogramming

Mogrify has generated preclinical evidence that its in vivo cell reprogramming technology can preserve and restore visual function in a model of retinal degeneration.

11th November, 2026

02.

PlaqueTec’s BIOPATTERN trial reaches 100 patients as NHS network expands to eight cardiac centres

Cambridge-based PlaqueTec has recruited its 100th participant into a clinical trial investigating the biology of coronary artery disease and potential new approaches to more personalised treatment. The trial has expanded to eight NHS cardiac centres across England.

10th November, 2026

03.

T-Cypher Bio expands into purpose-built laboratory space at Abingdon Science Park

Oxford-based biotechnology company T-Cypher Bio has relocated its headquarters to a newly built 12,000 sq ft facility at Abingdon Science Park, providing additional laboratory capacity as it advances its pipeline of T cell engager therapies.

9th November, 2026

04.

£30m venture philanthropy fund launched to accelerate development of new myeloma treatments

The DFN Foundation and philanthropist David Forbes-Nixon OBE have committed £15 million towards a new £30 million venture philanthropy fund, aimed at supporting early-stage biotech ventures developing potential treatments, diagnostics and technologies for myeloma.

Editor's Selects.

AI in Science Writing and the Imitation of Understanding

First Human Egg ‘Rejuvenation’ Offers Hope for Older IVF Patients

A Simple Pad Could Transform Cervical Cancer Screening

A New Device Could Improve How Progesterone is Delivered in Early Pregnancy

Our Partners.

Stay up-to-date. Connect with BioFocus on LinkedIn or subscribe to our mailing list.

bottom of page